S-1+Oxaliplatin vs.S-1+Cisplatin First-line Treatment of Advanced or Recurrent Non-intestinal Type Gastric Adenocarcinoma Patients

NCT01824459 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

576

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: S-1
DRUG: Oxaliplatin
DRUG: Cisplatin

Sponsor

Sun Yat-sen University

Collaborators

[object Object]